These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24525259)

  • 41. Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment.
    Brooks BW; Berninger JP; Kristofco LA; Ramirez AJ; Stanley JK; Valenti TW
    Prog Mol Biol Transl Sci; 2012; 112():231-58. PubMed ID: 22974742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LC-MS analysis in the aquatic environment and in water treatment technology--a critical review. Part II: Applications for emerging contaminants and related pollutants, microorganisms and humic acids.
    Zwiener C; Frimmel FH
    Anal Bioanal Chem; 2004 Feb; 378(4):862-74. PubMed ID: 14673565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Achievements and future trends in the analysis of emerging organic contaminants in environmental samples by mass spectrometry and bioanalytical techniques.
    Farré M; Kantiani L; Petrovic M; Pérez S; Barceló D
    J Chromatogr A; 2012 Oct; 1259():86-99. PubMed ID: 22877973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PETRORISK: a risk assessment framework for petroleum substances.
    Redman AD; Parkerton TF; Comber MH; Paumen ML; Eadsforth CV; Dmytrasz B; King D; Warren CS; den Haan K; Djemel N
    Integr Environ Assess Manag; 2014 Jul; 10(3):437-48. PubMed ID: 24687890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In response: governmental perspective.
    Maack G
    Environ Toxicol Chem; 2014 Sep; 33(9):1918-20. PubMed ID: 25138029
    [No Abstract]   [Full Text] [Related]  

  • 46. Targeted eco-pharmacovigilance as an optimized management strategy for adverse effects of pharmaceuticals in the environment.
    Wang J; Li S; Zhu Y; Guo J; Liu J; He B
    Environ Toxicol Pharmacol; 2021 Feb; 82():103565. PubMed ID: 33321209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption.
    Vulliet E; Cren-Olivé C
    Environ Pollut; 2011 Oct; 159(10):2929-34. PubMed ID: 21570166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data.
    Houtman CJ; Kroesbergen J; Lekkerkerker-Teunissen K; van der Hoek JP
    Sci Total Environ; 2014 Oct; 496():54-62. PubMed ID: 25058934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmaceuticals as pollution].
    Grung M; Langford K; Thomas KV
    Tidsskr Nor Laegeforen; 2012 May; 132(10):1249-51. PubMed ID: 22669389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.
    Adler NE; Koschorreck J; Rechenberg B
    Water Sci Technol; 2008; 57(1):91-7. PubMed ID: 18192745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals.
    Perazzolo C; Morasch B; Kohn T; Magnet A; Thonney D; Chèvre N
    Environ Toxicol Chem; 2010 Aug; 29(8):1649-57. PubMed ID: 20821616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Environmental risk assessment of medicinal products for human use according to European Commission recommendations.
    Huschek G; Hansen PD; Maurer HH; Krengel D; Kayser A;
    Environ Toxicol; 2004 Jun; 19(3):226-40. PubMed ID: 15101038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeating history: pharmaceuticals in the environment.
    Ankley GT; Brooks BW; Huggett DB; Sumpter JP
    Environ Sci Technol; 2007 Dec; 41(24):8211-7. PubMed ID: 18200843
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
    Kar S; Roy K
    Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment.
    Guo J; Sinclair CJ; Selby K; Boxall AB
    Environ Toxicol Chem; 2016 Jun; 35(6):1550-9. PubMed ID: 26799673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk assessment of chemicals and pharmaceuticals in the pediatric population: a workshop report.
    Pohl HR; van Engelen JG; Wilson J; Sips AJ
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):83-95. PubMed ID: 15896447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioaccumulation and analytics of pharmaceutical residues in the environment: A review.
    Puckowski A; Mioduszewska K; Łukaszewicz P; Borecka M; Caban M; Maszkowska J; Stepnowski P
    J Pharm Biomed Anal; 2016 Aug; 127():232-55. PubMed ID: 26968887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of chlorination on the persistence of pharmaceuticals in the environment.
    Glassmeyer ST; Shoemaker JA
    Bull Environ Contam Toxicol; 2005 Jan; 74(1):24-31. PubMed ID: 15768494
    [No Abstract]   [Full Text] [Related]  

  • 59. Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry.
    Grabic R; Fick J; Lindberg RH; Fedorova G; Tysklind M
    Talanta; 2012 Oct; 100():183-95. PubMed ID: 23141327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. WikiPharma - a freely available, easily accessible, interactive and comprehensive database for environmental effect data for pharmaceuticals.
    Molander L; Gerstrand M; Rudén C
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):367-71. PubMed ID: 19720105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.